Tag: European

European Union-funded medical sterilization equipment and training boosts health protection – Lao People’s Democratic Republic (the)

This week, more than US$160 000 of WHO-procured hospital sterilization equipment will be dispatched to healthcare facilities across the country, as part of ongoing efforts by the Ministry of Health, WHO and the European Union (EU) to tackle COVID-19 and other infectious diseases, and strengthen the health system’s capacity for future health threats including antimicrobial resistance.

The donation – a mixture of 12 units of 150L and 200L autoclaves used for industrial-scale sterilisation of medical equipment – have been provided to healthcare facilities across the country. The units will greatly expand the ability of provincial hospitals to conduct high-volume, high-temperature sterilisation of surgical and medical devices.

The donation accompanies an EU-funded, WHO-delivered infection prevention and control training for 243 nurses, doctors and midwifes in central, provincial and district hospitals in Luang Prabang, Oudomxay, Champasack, Xieng Khouang, Xekong and Vientiane provinces, and Vientiane Capital.

“Improving the quality and safety of healthcare services for our people is our Ministry’s key focus,” said Dr. Bounfeng Phoummalaysith, Minister of Health. “This generous EU assistance will enhance infection prevention and control, an essential part of improving the quality of healthcare, and strengthen our health system now and in the future.”

“This timely donation and support from the European Union is greatly appreciated, it will improve patient safety by reducing the incidence of healthcare associated infections,” said the Ministry of Health’s Dr. Somchan Thounsavath, Deputy Director General, Department of Healthcare and Rehabilitation.

“Providing the greatest level of quality care, and health for all, is our top priority, and this contribution allows us to better protect healthcare workers, patients, and communities.”

The autoclaves, providing 2,000L of sterilization capacity in total, have been supported by training for health care workers on strengthening infection prevention knowledge, skills, monitoring, evaluation, and developing tailored plans to address gaps in infection prevention and control in each facility. Under the leadership of the Nursing and Midwifery Division, Department and Healthcare and Rehabilitation-Ministry of Health, WHO provided the training, as well as supporting assessments.

“The European Union is proud to help reinforce the healthcare system in Lao PDR’ and assist health workers be better equipped with knowledge and equipment,” said Ina Marčiulionytė, the EU Ambassador to Lao PDR.

“Together with our partners at WHO and the Government of Lao PDR, we will continue working to make sure citizens all over Lao PDR receive improved access to healthcare and support during the COVID-19 pandemic. The EU, with the rest of Team Europe, remain committed to support the country in building back better and stronger.”

Amid the COVID-19 pandemic, infection prevention and control has been crucial in reducing the spread of the virus in medical facilities, as well as other diseases. Hundreds of millions of people are affected globally every year by avoidable infections in health care, often related to poor sterilization or hygiene practises or equipment.

“While no one should catch an infection while receiving health care. It does happen, but we can stop it with the right tools and skills,” said WHO Representative Dr. Ying-Ru Lo. “Infection prevention and control measures are one of the most effective ways to prevent infections including antimicrobial resistant germs in health facilities, improve the quality and safety of healthcare services.”

“The EU’s significant contribution has and will help curve the spread of COVID-19 and other diseases, particularly for vulnerable people in health facilities, and directly save lives. We greatly appreciate their generous contribution to improving health.”

This support is part of wider collaboration between the EU and WHO to support health in Lao PDR. The recent donation is part of several million dollars of COVID-19-addressing activities to improve health and wellbeing for people and communities, including support for laboratories and disease surveillance, health emergency response, improvements in clinical management, infection prevention and control, improving water, sanitation and hygiene, and logistics strengthening.

European Commission Proposes Amending Transitional Provisions in Medical Devices and In Vitro Diagnostics Regulations // Cooley // Global Law Firm

&#13

On 6 January 2023, the European Fee adopted a proposal to amend the transitional provisions of Regulation (EU) 2017/745 on health-related equipment (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic healthcare equipment (IVDR).

The proposal aims to stop health care device shortages on the European Financial Area (EEA) market place. The proposed amendments introduce an extension to the transitional durations proven in the polices to deliver clinical device makers much more time to bring their gadgets into conformity with the specifications of the polices. In the circumstance of the MDR, the duration of the proposed extension is contingent on the possibility classification of devices.

The proposed amendments have been mentioned through a meeting of the Employment, Social Plan, Wellness and Customer Affairs Council held on 9 December 2022. Throughout the assembly, the frustrating majority of wellness ministers of the EU member states welcomed the proposed prolongation of the transitional intervals recognized in the MDR and the IVDR, and they underlined the urgency of delaying implementation of the laws. (For a lot more information on the assembly, refer to Cooley’s similar Productwise weblog write-up.)

The European Commission’s proposal to amend the transitional provisions proven in the MDR and the IVDR contains the subsequent things:

  • Extension of the transitional time period for bigger hazard (Course III and IIb implantable units) health-related units included by a CE certification of conformity issued before 26 May possibly 2021 in accordance with the Professional medical Gadgets Directive (MDD) or the Lively Implantable Clinical Units Directive (AIMDD) from 26 May 2024 to 31 December 2027.
  • Extension of the transitional interval for medium- and low-danger (other Course IIb units, Course IIa and sure Class I products) health-related gadgets accredited prior to 26 May perhaps 2021 in accordance with the MDD to 31 December 2028.
  • Introduction of a transitional period for Class III customized-made implantable gadgets until 26 May well 2026, provided that an software for a conformity evaluation is lodged with a notified entire body by the professional medical device maker by 26 May possibly 2024, and a agreement with the notified entire body is signed ahead of 26 September 2024.
  • Extension of the period of validity of certificates issued in accordance with the MDD and the AIMDD based on the product’s hazard course.
  • Removing of the “sell-off” deadline set up in Post 120.4 of the MDR and Short article 110.4 of the IVDR for healthcare equipment and in vitro diagnostics (IVDs), respectively, which usually means that healthcare devices and IVDs certified in accordance with the MDD, the AIMDD and the In Vitro Diagnostics Directive (IVDD) prior to the conclusion of the transitional period of time recognized in the MDR and the IVDR will be permitted to continue to be on the EEA market.

In accordance to the proposal, professional medical gadgets and IVDs would gain from the extended transitional periods if they fulfill sure conditions. Medical gadgets and IVDs ought to not present an unacceptable risk to individual and user wellbeing and basic safety. Furthermore, the application of the prolonged transitional durations would not address units that have gone through considerable variations in terms of their style and supposed reason. Companies also have to have commenced the process of transitioning their products to the MDR’s needs.

Motives driving proposed extension of transitional durations

Despite development in the implementation of the MDR and the IVDR, there have been considerable delays in the changeover of healthcare equipment and IVDs to the new procedures, as properly as worries in respecting the primary changeover deadlines delivered in the regulations. Restricted notified body availability and capacity, shortages in the source of raw supplies in the EU and deficiency of preparedness of manufacturers to carry their products into conformity with the rules are amongst the elements that have contributed to these delays and issues. To avert the risk of disruption to the provide and availability of professional medical products and IVDs on the EU market that could effect the protection of affected individual wellbeing, the European Commission proposed to allow for protected legacy gadgets to keep on being on the current market in the EEA soon after the stop of the at present relevant transitional period of time.

Subsequent methods

The proposal adopted by the European Fee will be regarded as for adoption by the European Parliament and the European Council by way of a co-selection process.

If adopted in its current variety, the proposed extension of the transitional provisions would have quite a few implications for the health-related gadget field. If you have any issues about the result of the extension of the MDR’s transitional interval, you should get to out to a member of Cooley’s life sciences regulatory staff.

Cooley lawful trainee Anastasia Vernikou also contributed to this warn. 

&#13

European Commission Proposes Extending Transition Period Foreseen in Medical Devices Regulation // Cooley // Global Law Firm

The implementation of Regulation (EU) 2017/745 on medical devices (MDR) was discussed on the second day of the meeting of the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) on 9 December 2022. The European Commission proposes to extend the transition period currently foreseen in the MDR for devices certified in accordance with the Medical Device Directive (MDD) and the Active Implantable Medical Device Directive (AIMDD) through legislative amendment of the transitional provisions of the MDR. The extension of the transition period would be in the form of a staggered approach based on the risk classification of devices.

The transition period foreseen in the MDR provides that the deadline for recertification of medical devices in accordance with the regulation is 26 May 2024. A broad range of stakeholders, including the medtech industry, consider this timeline to be unattainable and have called on the European Commission to extend the recertification deadline. This extension would be based on the risk classification of devices and would mean that devices certified in accordance with the MDD and the AIMDD will remain on the market in the European Economic Area (EEA) after the end of the currently applicable transition period.

The European Commission proposes the following targeted legislative amendments:

  • Extension of the transitional provisions foreseen in the MDR based on the risk class of each device.
    • 26 May 2027 for high-risk (Class III and Class IIb) medical devices
    • 26 May 2028 for medium- and low-risk (Class IIa and Class I) medical devices
  • Elimination of the sell-off date of 26 May 2025 for medical devices that are already available on the EEA market to prevent safe medical devices from being removed from the market.

EU Commissioner for Health and Food Safety Stella Kyriakides noted that the proposed amendments would apply solely to medical devices that are safe for patients.

Following discussion with the health ministers of the EU member states, Kyriakides acknowledged the need for interim measures in relation to CE certificates of conformity previously issued for medical devices that have expired or will expire soon.

Shortly after the EPSCO meeting concluded, the European Commission published a position paper prepared by the Medical Device Coordination Group. The purpose of the position paper is to ensure a uniform approach to the application of market surveillance measures to bridge the gap between the expiration of certificates and the issuance of new certificates. The position paper provides guidance on how competent authorities should apply Article 97 MDR to devices that do not comply with the MDR due to expiration of their CE certificates of conformity issued in accordance with the MDD and the AIMDD before being certified under the MDR.

In addition to the proposed legislative amendments, the European Commission intends to undertake a comprehensive evaluation of the MDR by May 2027. The purpose of the evaluation is to identify structural problems with the MDR, as well as potential medium- and long-term solutions to these concerns. Moreover, the European Commission intends to fund actions to support the implementation of the MDR under the EU4Health programme starting in early 2023.

If you have any questions about the effect of the extension of the MDR transition period, please reach out to a member of your Cooley life sciences regulatory team.


Supporting capacity building in Ukrainian Hospitals: Polish Medical Mission organizes shipments of medical equipment funded by the Financial Mechanism of European Economic Area and the Norwegian Financial Mechanism – Ukraine

By Rowan Joffe Mclachlan:

Polish Healthcare Mission (PMM) done customized deliveries of clinical tools for 50 Hospitals across 22 Oblasts of Ukraine on the 6th of December. Above the course of the 6-month project and many thanks to funding from Norwegian Funds, PMM was equipped to help the hospitals in their provision of an average of 255,600 people a thirty day period with lifesaving health care care. The full task benefit was 1,000,000 EUR.

Just after the 2022 invasion of Ukraine the health care program across Ukraine was under intensive force, with a substantial boost in both equally war wounded and IDP’s positioning all oblasts under pressure. This necessitated the enhance in potential for hospitals across the state.

In June of this 12 months, PMM began the system of range and get in touch with of hospitals that PMM could access and guidance. PMM determined the 50 hospitals most in essential will need of aid that had been accessible for shipping. Following setting up call with hospitals, PMM recognized the lists of items that they most necessary in buy to guidance their things to do. This was facilitated with the advancement of tailor made get sorting software program in cooperation with Qualtrics. Every single specific healthcare facility was directed to buy a custom shipment to assist their particular wants and things to do. These products have been then acquired on the Polish professional sector and shipped straight to hospitals.

The tools involved advanced products these as cardio screens, autoclaves, electro suctions, USG’s and centrifuges for surgical and ICU departments. In addition, substantial quantities of surgical instruments ended up bought and dispersed as nicely a broad wide range of insignificant items of gear important for the day-to-day operations of the professional medical departments. Also sent were a quantity of incubators to neonatal wards across the nation, PMM can now report that those incubators have presently supported the delivery and care of more than 1,000 newborns.

Together with these clinical machines was sent a substantial number of critical consumables surgical masks, robes, disinfectant and also frequent medicines that were being supplied by our in-variety donors.

The distribution of these goods was at situations difficult provided the security scenario in Ukraine and the injury to infrastructure and PMM is indebted to our associates, both of those NGO and commercial. The Ukrainian NGO UNITERS supported over 40 deliveries to really hard-to-attain regions of the place, allowing for our assist to achieve the points in which it was desired most. In the meantime, in Poland the business logistics agency ROBANO Express Thermo Logistics shared each their warehouse place, supply drivers and significant know-how to let a really helpful collaboration. Put together with PMM’s committed logistic crew it was doable to establish a monitored and accountable chain of distribution that stretched from suppliers to beneficiary hospitals.

Considering the fact that the shut of the challenge PMM has now began conducting new shipments of professional medical gear to equally hospitals by now supported and recently recognized ones. Developing on the networks and techniques founded throughout this undertaking PMM will be able to go on our assist of Ukrainian hospitals into 2023.